Few Years Later

The US Food and Drug Administration has given 23andMe authorization to market its direct-to-consumer health risk tests, as GenomeWeb has reported. The company will now offer 10 health risk tests, including ones for Parkinson's disease, late-onset Alzheimer's disease, and celiac disease, it adds.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.